Provided by Tiger Trade Technology Pte. Ltd.

Fidelity Disruptive Medicine ETF

31.98
+0.42311.34%
Post-market: 31.980.00000.00%16:10 EDT
Volume:5K
Turnover:161.19K
Market Cap:51.93M
PE:- -
High:32.23
Open:31.63
Low:31.63
Close:31.56
52wk High:32.89
52wk Low:23.48
Shares:1.62M
Float Shares:1.62M
Volume Ratio:0.75
T/O Rate:0.31%
Dividend:- -
Dividend Rate:- -
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

10x Genomics Q2 EPS $(0.14) Beats $(0.24) Estimate, Sales $151.000M Beat $146.788M Estimate

Benzinga Earnings
·
Aug 07

10X Genomics Q2 Revenue USD 151 Million Vs. IBES Estimate USD 146.8 Million

Reuters
·
Aug 07

LifeStance Raises Fy2026 Revenue Outlook to $1.685 Billion-$1.725 Billion

Reuters
·
Aug 06

LifeStance Health Group, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 06

Lifestance Health Swings to Q2 Profit as Revenue Rises; Raises 2026 Revenue Guidance

MT Newswires Live
·
Aug 06

Lifestance Health Lifts Outlook After Strong Q2 Results

TIPRANKS
·
Aug 06

LifeStance Q2 FY26 Net Income Turns to USD 23.6 Million; Revenue Rises 26% to USD 435.4 Million

Reuters
·
Aug 06

Lifestance Health Q2 Revenue USD 435.4 Million Vs. IBES Estimate USD 414.6 Million

Reuters
·
Aug 06

Lifestance Health Q2 EPS USD 0.06

THOMSON REUTERS
·
Aug 06

Lifestance Health Group, - Approves New $100 Mln Share Repurchase Program

THOMSON REUTERS
·
Aug 06

Lifestance Health Outlook Q3 Revenue USD 420-440 Million

THOMSON REUTERS
·
Aug 06

Lifestance Health Group Inc Says Raising Full Year Revenue Outlook to $1.685 Bln to $1.725 Bln

THOMSON REUTERS
·
Aug 06

Lifestance Reports Strong Second Quarter 2026 Financial Results and Raises Full Year Outlook

THOMSON REUTERS
·
Aug 06

LifeStance Reports Strong Second Quarter 2026 Financial Results and Raises Full Year Outlook

GlobeNewswire
·
Aug 06

Revvity Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 06

Envista Q2 Sales Rise on Segments Growth

Reuters
·
Aug 06

Thermo Fisher Scientific Inc : Stifel Raises Target Price to $650 from $600

THOMSON REUTERS
·
Aug 05

LivaNova Q2 FY26 GAAP Diluted EPS Rises to $1.93; Revenue Increases 10.8% Year over Year to $390.6 Million

Reuters
·
Aug 05

UK's LivaNova Q2 Revenue Beats Estimates; Lifts 2026 Outlook

Reuters
·
Aug 05

LivaNova: Deal Expected to Support Increased Oxygenator Output over Time, Strengthening Co Ability to Satisfy Unmet Customer Demand

THOMSON REUTERS
·
Aug 05